Skip to main content Accessibility help

Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis

  • B. S. Gendeh (a1), H. Said (a1), A. G. Gibb (a2), N. S. Aziz (a3), N. Kong (a4) and Z. M. Zahir (a5)...


A prospective study was undertaken of 10 chronic renal failure patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) complicated by repeated bouts of peritonitis treated with gentamicin. Each 10-day treatment course consisted of a 120 mg loading dose, followed by 16 mg in 21 of peritoneal dialysate, given four times a day. Serum gentamicin analysed by enzyme immunoassay showed a mean level of 5.2 µg/ml, (range 3.7 to 6.6 µg/ml) four hours after the loading dose. Similar levels, well within the therapeutic range, were maintained on the 3rd, 5th, 7th and 9th days of intraperitoneal gentamicin therapy, suggesting no accumulation of gentamicin in the serum. Pure tone audiometry, electronystagmography and clinical assessment were performed during each course of treatment. Although no evidence of ototoxicity was found during the first two courses of gentamicin, but disequilibrium and bobbing oscillopsia were present during the third and fourth courses of gentamicin. These findings could be explained by cumulative injury to the vestibular apparatus caused by repeated therapeutic insults.


Corresponding author

Dr B. S. Gendeh, Research Register, ENT Department, North Riding Infirmary, Newport Road, Middlesborough, Cleveland, TS1 5JE, UK.


Hide All
Federspil, P., Scahtzle, W., Tiesler, E. (1976) Pharmacokinetics ototoxicity of gentamicin, tobramycin and amikacin. Journal of Infectious Diseases 143 (Supplement): 200205
Gary, N. E. (1972) Peritoneal clearance and removal of gentamicin. Journal of Infectious Diseases 124 (Supplement): 9697
Gendeh, B. S., Said, H., Gibb, A. G., Aziz, N. S., Zahir, Z. M. (1991) Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity. Journal of Laryngology and Otology 105: 9991001
Hawkin, J. E., Johnson, L. G., Aran, J. M. (1967) Comparative tests of gentamicin toxicity. Journal of Infectious Diseases 417426
Line, D. H., Poole, G. W., Waterworth, P. M. (1970) Serum streptomycin levels and dizziness. Tubercle 51 (1): 7681
Mohan, W. A., Ecer, J. I., Fenthon, S. S., Coltron, D. C. (1973) Studies of gentamicin clearance during peritoneal and hemodialysis. Clinical Research 21: 10181019
Ramsden, R. T., Ackrill, P. (1982) Bobbing oscillopsia from gentamicin toxicity. British Journal of Audiology 16 147150
Selvador, P., Christina, C. (1981) Pharmacokinetics of gentamicin patients undergoing continuous ambulatory peritoneal dialysis. Journal of Antimicrobial Chemotherapy 19: (4): 605607
Smithivas, T., Hyams, P. J., Matalon, P., Simberkoff, M. S., Rahal, J. J. (1971) The use of gentamicin in peritoneal dialysis. Journal of Infectious Diseases Supplement: 7783
Tran Ba Huy, P., Deffrennes, D. (1988) Aminoglycoside ototoxicity: influence of dosage regimen of drug uptake and correlation between membrane binding and some clinical features. Acta Otolaryngology 105: (5–6) 511515
Voldrich, L. (1965) The kinetics of streptomycin, kanamycin and neomycin xin the inner ear. Acta Otolaryngology 66: 243.


Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis

  • B. S. Gendeh (a1), H. Said (a1), A. G. Gibb (a2), N. S. Aziz (a3), N. Kong (a4) and Z. M. Zahir (a5)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed